Jean-Marie Michot

Jean-Marie Michot

UNVERIFIED PROFILE

Are you Jean-Marie Michot?   Register this Author

Register author
Jean-Marie Michot

Jean-Marie Michot

Publications by authors named "Jean-Marie Michot"

Are you Jean-Marie Michot?   Register this Author

79Publications

4011Reads

29Profile Views

Haemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitors: a descriptive case study and literature review.

Br J Haematol 2020 Apr 3. Epub 2020 Apr 3.

Service de Médecine Interne et d'Immunologie Clinique, AP-HP Université Paris-Saclay, Hôpital Bicêtre, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16630DOI Listing
April 2020

Burkitt and Burkitt-Like Lymphomas: a Systematic Review.

Curr Oncol Rep 2020 Mar 6;22(4):33. Epub 2020 Mar 6.

Département d'Hématologie, Institut de Cancérologie Gustave Roussy, 114 Rue Edouard Vaillant, 94810, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-020-0898-8DOI Listing
March 2020

The 2016-2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study.

Eur J Cancer 2020 Mar 12;130:39-50. Epub 2020 Mar 12.

Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre, Service de Médecine Interne and Immunologie clinique, Le Kremlin-Bicêtre, France; INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin Bicêtre, France; Université Paris Sud, UMR 1184, Le Kremlin Bicêtre, France; CEA, DSV/iMETI, IDMIT, Fontenay-aux-Roses, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2020.02.010DOI Listing
March 2020

Prevalence and Clinical Patterns of Ocular Complications Associated With Anti-PD-1/PD-L1 Anticancer Immunotherapy.

Am J Ophthalmol 2019 06 15;202:109-117. Epub 2019 Feb 15.

Service d'Ophtalmologie, DHU Vision & Handicaps, Centre de référence pour les maladies rares en ophtalmologie (OPHTARA), Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France; Université Paris-Sud, Le Kremlin-Bicêtre, France; Immunology of Viral Infections and Autoimmune Diseases, INSERM U1184, Le Kremlin-Bicêtre, France; Department of Immunology of Viral and Auto-immune Disease, UMR1184, CEA, CEA, DSV/iMETI, IDMIT, Fontenay-aux-Roses, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajo.2019.02.012DOI Listing
June 2019

Reply to: "Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?"

J Hepatol 2019 03 5;70(3):566-567. Epub 2018 Dec 5.

AP-HP Hôpital Paul Brousse, Centre Hépato-Biliaire, Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay Villejuif, DHU Hepatinov, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.11.016DOI Listing
March 2019

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.

Lancet Haematol 2019 Jan 4;6(1):e48-e57. Epub 2018 Dec 4.

Service de Médecine Interne and Immunologie Clinique, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre, France; Université Paris Sud, Centre de Recherche en Immunologie des Infections Virales et des Maladies Auto-Immunes, INSERM, Le Kremlin-Bicêtre, France; Division d'Immunovirologie, Commissariat à l'Energie Atomique et aux Energies Alternatives, Fontenay-aux-Roses, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30175-3DOI Listing
January 2019

[Management of adverse events associated with cancer immunotherapy].

Rev Prat 2019 Jan;69(1):39-48

Assistance publique- Hôpitaux de Paris, hôpital Bicêtre, service de médecine interne et immunologie clinique, Le Kremlin-Bicêtre, France. UniversitéParis-Sud,Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
January 2019

Reply to: "Incidence of grade 3-4 liver injury under immune checkpoints inhibitors: A retrospective study".

J Hepatol 2018 12 5;69(6):1397-1398. Epub 2018 Oct 5.

AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay Villejuif, DHU Hepatinov, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.09.006DOI Listing
December 2018

Reply to: "Mortality due to immunotherapy related hepatitis".

J Hepatol 2018 10 7;69(4):978-979. Epub 2018 Aug 7.

AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Villejuif, F-94800, France, DHU Hepatinov, Villejuif, France; Inserm, Unité 1193, Villejuif, Université Paris-Saclay, F-94800, France; Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay, Villejuif, F-94800, France; Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01688278183226
Publisher Site
http://dx.doi.org/10.1016/j.jhep.2018.07.009DOI Listing
October 2018

Reply to: "Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?"

J Hepatol 2018 08;69(2):550-551

AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, INSERM, Unité 1193, Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay, DHU Hepatinov, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.04.019DOI Listing
August 2018

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.

J Hepatol 2018 06 8;68(6):1181-1190. Epub 2018 Feb 8.

AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire; Univ Paris-Sud, UMR-S 1193, Université Paris-Saclay; Inserm, Unité 1193, Université Paris-Saclay; Hepatinov, Villejuif, F-94800, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2018.01.033DOI Listing
June 2018

Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1.

Eur J Cancer 2018 06 23;96:91-104. Epub 2018 Apr 23.

Department of Radiology, Gustave Roussy Cancer Campus, Villejuif, France; Université Paris-Saclay, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.03.006DOI Listing
June 2018

Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy.

Ann Rheum Dis 2018 03 27;77(3):468-470. Epub 2017 Feb 27.

Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service de Médecine Interne et Immunologie clinique, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2016-210820DOI Listing
March 2018

Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease.

Eur J Cancer 2018 03 10;91:21-29. Epub 2018 Jan 10.

Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre, Service de Médecine Interne et Immunologie Clinique, F-94275, Le Kremlin-Bicêtre, France; INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, F-94276, Le Kremlin-Bicêtre, France; Université Paris Sud, UMR 1184, F-94276, Le Kremlin-Bicêtre, France; CEA, DSV/iMETI, IDMIT, F-92265, Fontenay-aux-Roses, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.12.008DOI Listing
March 2018

Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma.

Eur J Cancer 2018 03;91:136-144

Department of Medicine Oncology, Gustave Roussy Comprehensive Cancer Center, F-94805 Villejuif, France; Gustave Roussy, Université Paris-Saclay, Département D'hématologie, Villejuif F-94805, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.12.015DOI Listing
March 2018

Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door.

Eur J Cancer 2018 03 3;92:1-10. Epub 2018 Feb 3.

Drug Development Department, Gustave Roussy, Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Kremlin-Bicêtre, France; Gustave Roussy Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.12.020DOI Listing
March 2018

Ibrutinib-Induced Neutrophilic Dermatosis.

Am J Dermatopathol 2018 Mar;40(3):198-200

Département d'Hématologie, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00000372-201803000-0000
Publisher Site
http://dx.doi.org/10.1097/DAD.0000000000000862DOI Listing
March 2018

[Hodgkin lymphoma: Current and future therapeutic strategies].

Bull Cancer 2018 Jan 27;105(1):81-98. Epub 2017 Dec 27.

Cancer campus Grand-Paris, Gustave-Roussy cancer comprehensive center, département d'hématologie, 114, rue Édouard-Vaillant, 94805 Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.11.008DOI Listing
January 2018

Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma.

Eur J Nucl Med Mol Imaging 2017 Nov 21;44(12):2018-2024. Epub 2017 Jun 21.

Department of Hematology, Gustave Roussy and Université Paris Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-017-3758-5DOI Listing
November 2017

Challenges and perspectives in the immunotherapy of Hodgkin lymphoma.

Eur J Cancer 2017 11 9;85:67-77. Epub 2017 Sep 9.

Département des Innovations Thérapeutiques et des Essais Précoces, Gustave Roussy, 114 Rue Edouard-Vaillant, F-94805 Villejuif, France; Département d'Oncologie Médicale, Institut Jules Bordet, rue Héger Bordet 1, B-1000 Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.08.014DOI Listing
November 2017

Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis.

Eur J Cancer 2017 09 10;82:34-44. Epub 2017 Jul 10.

Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre, Service de Médecine Interne et Immunologie Clinique, F-94275 Le Kremlin-Bicêtre, France; INSERM, U1184, Immunology of Viral Infections and Autoimmune Diseases, F-94276 Le Kremlin-Bicêtre, France; Université Paris Sud, UMR 1184, F-94276 Le Kremlin-Bicêtre, France; CEA, DSV/iMETI, IDMIT, F-92265 Fontenay-aux-Roses, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.05.032DOI Listing
September 2017

Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies.

Eur J Cancer 2017 08;81:135-137

Drug Development Department, Université Paris-Saclay, Villejuif, F-94805, France; Pharmacy Department, Université Paris-Saclay, Villejuif, F-94805, France; Département d'Hématologie, Université Paris-Saclay, Villejuif, F-94805, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.05.017DOI Listing
August 2017

Immune-related bone marrow failure following anti-PD1 therapy.

Eur J Cancer 2017 07 17;80:1-4. Epub 2017 May 17.

Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre, Service de Médecine Interne et Immunologie clinique, F-94275 Le Kremlin-Bicêtre, France; Université Paris Sud, UMR 1184, F-94276 Le Kremlin-Bicêtre, France; CEA, DSV/iMETI, IDMIT, F-92265 Fontenay-aux-Roses, France; INSERM, U1184, Immunology of Viral Infections and Autoimmune Diseases, F-94276 Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.04.004DOI Listing
July 2017

[Consortium for detection and management of lung damage induced by bleomycin].

Bull Cancer 2016 Jul-Aug;103(7-8):651-61. Epub 2016 May 27.

Gustave-Roussy, département de médecine oncologique, 114, rue Édouard-Vaillant, 94800 Villejuif, France; Université Paris Descartes, UFR des sciences pharmaceutiques et biologiques, 75270 Paris cedex 06, France; Gustave-Roussy, département des innovations thérapeutiques et des essais précoces, 114, rue Édouard-Vaillant, 94800 Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.04.005DOI Listing
January 2017

A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm auto-immune hemolytic anemia in adults (the RAIHA study).

Am J Hematol 2017 Jan 10;92(1):23-27. Epub 2016 Nov 10.

Department of Internal Medicine, National Referral Center for Adult'Immune Cytopenias Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.24570
Publisher Site
http://dx.doi.org/10.1002/ajh.24570DOI Listing
January 2017

Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure.

J Clin Oncol 2016 11;34(31):3733-3739

Philippe Armand and Margaret A. Shipp, Dana-Farber Cancer Institute, Boston, MA; Vincent Ribrag and Jean-Marie Michot, Institut Gustave Roussy, Villejuif, France; Pier Luigi Zinzani, Institute of Hematology Seràgnoli, University of Bologna, Bologna, Italy; John Kuruvilla, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada; Ellen S. Snyder, Alejandro D. Ricart, Arun Balakumaran, and Shelonitda Rose, Merck, Kenilworth, NJ; and Craig H. Moskowitz, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.3467DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791838PMC
November 2016

Abscopal effect in a Hodgkin lymphoma patient treated by an anti-programmed death 1 antibody.

Eur J Cancer 2016 10 18;66:91-4. Epub 2016 Aug 18.

Drug Development Department, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France; Department of Radiation Oncology, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France; INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Université Paris-Saclay, F-94805, Villejuif, France; Univ Paris Sud, Université Paris-Saclay, F-94270, Le Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.06.017DOI Listing
October 2016

Late recurrent testicular seminoma: histological evidence is required.

Oncol Res Treat 2015 19;38(6):286-8. Epub 2015 May 19.

Department of Cancer Medicine, Gustave-Roussy Cancer Campus, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000430794DOI Listing
March 2016

Adenosine deaminase is a useful biomarker to diagnose pleural tuberculosis in low to medium prevalence settings.

Diagn Microbiol Infect Dis 2016 Mar 10;84(3):215-20. Epub 2015 Nov 10.

Université de Nantes, Inserm UMR 1087/CNRS UMR 6291, 44007 Nantes, France; L'institut du thorax, Service de Pneumologie, Hôpital G. et R. Laënnec, CHU de Nantes, 44093 Nantes cedex 1, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diagmicrobio.2015.11.007DOI Listing
March 2016

Two cases of immune thrombocytopenia associated with pembrolizumab.

Eur J Cancer 2016 Feb 10;54:172-174. Epub 2015 Dec 10.

APHP, service de médecine interne et immunologie, Hôpital Bicêtre, F-94270 Le Kremlin Bicêtre, France; University of Paris-Sud, F-94043 Kremlin-Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.10.073DOI Listing
February 2016

Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndrome.

Autoimmun Rev 2015 Aug 9;14(8):680-5. Epub 2015 Apr 9.

AP-HP, Hôpital Pitié-Salpêtrière, Centre national de référence maladies auto-immunes systémiques rares, Département de Médecine Interne et Immunologie Clinique, Paris, France; DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Faculté Paris 6, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2015.03.007DOI Listing
August 2015

Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease.

Transfusion 2015 Feb 23;55(2):357-63. Epub 2014 Sep 23.

Service de Médecine Interne et Immunologie Clinique, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Bicêtre, Le Kremlin-Bicêtre, France; Université Paris Sud 11, Le Kremlin-Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.12875DOI Listing
February 2015

Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.

Blood 2014 Aug 3;124(7):1119-26. Epub 2014 Jun 3.

Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Service de Médecine Interne 2, Centre National de Référence des Maladies Auto-Immune et Systémiques Rares, Paris, France; Université Pierre & Marie Curie Université Paris 06, Paris, France; INSERM, Unité Mixte de Recherche-S 945, Paris, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-12-543793DOI Listing
August 2014

Successful outcome of a corticodependent henoch-schönlein purpura adult with rituximab.

Case Rep Med 2014 1;2014:619218. Epub 2014 Apr 1.

Internal Medicine Department, Assistance Publique-Hôpitaux de Paris, Bicêtre Hospital, 94275 Le Kremlin-Bicêtre, France ; Faculty of Medicine Paris-Sud, 94276 Le Kremlin-Bicêtre Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/619218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988713PMC
May 2014

Haemophagocytic histiocyte in a peripheral blood film.

Br J Haematol 2014 Apr 28;165(2):163. Epub 2013 Dec 28.

Service d'Hématologie de l'Hôpital Paul Brousse, INSERM UMRS 935, Assistance Publique des Hôpitaux de Paris, Université Paris-Sud 11, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12697DOI Listing
April 2014

Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease.

Blood 2012 Mar 5;119(10):2228-33. Epub 2012 Jan 5.

Department of Clinical Immunology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-08-376012DOI Listing
March 2012